GlassScriptPhysician profile
Joseph J Corning
NPI 1669580569
$1,210.90
in general payments reported to CMS, 2019-2025
19 companies · $68.64 in 2025
The $68.64 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $311 · 2021: $71.78 · 2022: $21.70 · 2024: $130 · 2025: $68.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $226.88 | 2019-2020 | |
| Boston Scientific Corporation | $161.16 | 2019-2024 | Watchman Flx |
| Pfizer INC. | $115.18 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $89.93 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $75.05 | 2019 | |
| Medtronic, INC. | $71.78 | 2021 | |
| Amgen INC. | $60.17 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $59.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.32 | 2019-2020 | |
| Abbott Laboratories | $42.94 | 2019-2025 | Cardiomems |
| Preventice Services, LLC | $38.07 | 2020 | |
| Sanofi-Aventis U.S. LLC | $37.65 | 2019-2020 | |
| Amarin Pharma, INC. | $29.77 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $28.65 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Portola Pharmaceuticals, LLC | $17.30 | 2020 | |
| Lundbeck LLC | $13.91 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Corning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.